Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2014-03-31
2018-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The most common mode is nasal intermittent mandatory ventilation (NIMV). In NIMV, the interval between mechanical breaths is fixed and is determined by the frequency dialed by the clinician. Asynchrony between the infant's spontaneous breathing may exist since mechanical breaths delivered at fixed intervals can occur at different times over the inspiratory or expiratory phases of the infant's spontaneous breathing. Synchronized-NIMV is a mode similar to NIMV where the ventilator cycle is delivered in synchrony with the infant's spontaneous inspiration. This has been achieved by using techniques to detect the infant's spontaneous inspiration.
The advantages or disadvantages of synchronized compared to non-synchronized NIMV remain to be determined.
This study seeks to evaluate the effect of synchronized NIMV versus non-synchronized NIMV on ventilation and gas exchange in premature infants who require supplemental oxygen.
The hypothesis is that the use of flow synchronized nasal intermittent mandatory ventilation (S-NIMV) in comparison to non-synchronized NIMV will improve ventilation and gas exchange and reduce breathing effort.
The objective of the study is to compare the effect of flow synchronized-NIMV to non-synchronized-NIMV on tidal volume (VT), minute ventilation (VE), gas exchange, breathing effort, apnea and chest wall distortion in preterm neonates with lung disease.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of Non-Invasive Ventilation Use in Preterm Infants.
NCT02628821
Short Term Effects of Synchronized vs. Non-synchronized NIPPV in Preterm Infants.
NCT03289936
Is Synchronization More Effective During Noninvasive Ventilation in Immediately Extubated Preterm Infants?
NCT01664832
Does NIV-NAVA Improve Diaphragmatic Function in Preterm Infants
NCT05079412
Ventilator Weaning Outcome Between NIV-NAVA and Nasal CPAP (or IMV ) Modes in Premature Neonates
NCT04118400
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NIMV followed by S-NIMV
During the study infants assigned to this arm will undergo a 2-hour period of non-synchronized NIMV followed by a 2-hour period of Synchronized-NIMV.
non-synchronized NIMV
During the study each infant will undergo a 2-hour period of NIMV at a frequency of 30 cycles per minute.
NIMV will be provided by a time cycled, pressure limited neonatal ventilator (Puritan Bennett 840, Covidien, Boulder, CO).
Synchronized NIMV
During the study each infant will undergo a 2-hour period of S-NIMV at a frequency of 30 cycles per minute.
S-NIMV will be provided by a time cycled, pressure limited neonatal ventilator, with leak compensation capacity and nasal flow triggered ventilation (Puritan Bennett 840, Covidien, Boulder, CO). Synchronization will be achieved by the leak compensation software and the internal sensor of the ventilator.
S-NIMV followed by NIMV
During the study infants assigned to this arm will undergo a 2-hour period of synchronized NIMV followed by a 2-hour period of non-synchronized NIMV.
non-synchronized NIMV
During the study each infant will undergo a 2-hour period of NIMV at a frequency of 30 cycles per minute.
NIMV will be provided by a time cycled, pressure limited neonatal ventilator (Puritan Bennett 840, Covidien, Boulder, CO).
Synchronized NIMV
During the study each infant will undergo a 2-hour period of S-NIMV at a frequency of 30 cycles per minute.
S-NIMV will be provided by a time cycled, pressure limited neonatal ventilator, with leak compensation capacity and nasal flow triggered ventilation (Puritan Bennett 840, Covidien, Boulder, CO). Synchronization will be achieved by the leak compensation software and the internal sensor of the ventilator.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
non-synchronized NIMV
During the study each infant will undergo a 2-hour period of NIMV at a frequency of 30 cycles per minute.
NIMV will be provided by a time cycled, pressure limited neonatal ventilator (Puritan Bennett 840, Covidien, Boulder, CO).
Synchronized NIMV
During the study each infant will undergo a 2-hour period of S-NIMV at a frequency of 30 cycles per minute.
S-NIMV will be provided by a time cycled, pressure limited neonatal ventilator, with leak compensation capacity and nasal flow triggered ventilation (Puritan Bennett 840, Covidien, Boulder, CO). Synchronization will be achieved by the leak compensation software and the internal sensor of the ventilator.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receiving NIMV
* Requiring Fi02 \> 0.21 to keep Sp02 \> 90%
* Parental written informed consent
Exclusion Criteria
* Proven sepsis within 72 hours of the study
* Hypotension requiring pressors within 72 hours of the study
* Pneumothorax or pneumomediastinum within 72 hours of the study
* Current suspected necrotizing enterocolitis, spontaneous perforation or severe abdominal distention
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nelson Claure
Research Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nelson Claure, MSc, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Eduardo Bancalari, MD
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Holtz Childrens Hospital-Jackson Health System-University of Miami
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20130844
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.